Convergence Investment Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,975
| Closed | -$681K | – | 341 |
|
|
2018
Q3 | $681K | Sell |
3,975
-7,498
| -65% | -$1.28M | 0.14% | 181 |
|
|
2018
Q2 | $1.48M | Sell |
11,473
-5,942
| -34% | -$768K | 0.21% | 143 |
|
|
2018
Q1 | $1.79M | Sell |
17,415
-6,168
| -26% | -$635K | 0.23% | 150 |
|
|
2017
Q4 | $2.02M | Buy |
23,583
+1,939
| +9% | +$166K | 0.27% | 128 |
|
|
2017
Q3 | $1.84M | Buy |
+21,644
| New | +$1.84M | 0.26% | 146 |
|